Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate |
| |
Authors: | Manjari Lal Scott Priddy Lou Bourgeois Richard Walker Walt Pebley James Brown James Desai Michael J. Darsley Debra Kristensen Dexiang Chen |
| |
Affiliation: | 1. PATH, PO Box 900922, Seattle, WA 98121, USA;2. Oregon Freeze Dry Inc., 525 25th Ave SW, Albany, OR 97321, USA;3. TD Vaccines A/S, Aspvej 12, Rauf, 9520 Skørping, Denmark |
| |
Abstract: | Vaccination is considered the most cost-effective approach to preventing infectious diseases, yet better formulations and delivery methods for efficient distribution and administration of vaccines are needed, especially for low-resource settings. A fast-dissolving tablet (FDT) that could be packaged in a compact stackable blister sheet is a potentially attractive option for formulating oral vaccines, since it would minimally impact the cold chain and could potentially be administered directly to patients without reconstitution. This study focused on using one component of a live attenuated trivalent vaccine under development to produce a FDT for the prevention of diarrhea induced by enterotoxigenic Escherichia coli (ETEC). Ten formulations were prepared and freeze dried to produce FDTs. Three freezing conditions were explored, along with different drying and package sealing methods. Physical properties examined included structural integrity, dissolution time, moisture content, and glass transition temperature. Bacterial viability was tested by assaying for colony-forming units. The formulation compositions and freeze-drying parameters were adjusted in an iterative process to arrive at a promising formulation for the ETEC vaccine tablet. This formulation included sucrose and trehalose as cryoprotectants; phosphate and glutamate salts as buffers and stabilizers; and Natrosol®, polyvinylpyrrolidone, and mannitol as binders. The process loss in viability during freeze drying was less than 0.3 log10 (50% recovery) for the optimized vaccine tablet formulation. The final tablets were robust, disintegrated in less than 10 s, and preserved the bacteria at 2–8 °C for at least 12 months with less than 0.4 log10 loss (40% recovery) in viability during storage. This study indicates that the FDT produced by freeze drying directly in a blister sheet could be a practical option for formulating ETEC vaccines for oral immunization and help to facilitate delivery of lifesaving vaccines, particularly in low-resource settings. |
| |
Keywords: | ETEC, enterotoxigenic Escherichia coli FDT, fast-dissolving tablet Tg, glass transition temperature |
本文献已被 ScienceDirect 等数据库收录! |
|